unoprostone isopropyl

unoprostone isopropyl (RESCULA) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

RESCULA is a marketed brand name for unoprostone isopropyl. Check FDA Drugs@FDA for the current US label holder and prescribing information.

unoprostone isopropyl has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.